Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Breast Neoplasms 485Carcinoma, Non-Small-Cell Lung 440Prostatic Neoplasms 292Lung Neoplasms 170Stomach Neoplasms 140Neoplasms 114Squamous Cell Carcinoma of Head and Neck 110Neoplasm Metastasis 98Head and Neck Neoplasms 97Esophageal Neoplasms 71Ovarian Neoplasms 57Pancreatic Neoplasms 42Urinary Bladder Neoplasms 39Sarcoma 39Nasopharyngeal Carcinoma 36Carcinoma, Squamous Cell 30Triple Negative Breast Neoplasms 28Carcinoma, Ovarian Epithelial 28Adenocarcinoma of Lung 27Adenocarcinoma 27Esophageal Squamous Cell Carcinoma 26Parkinson Disease 4, Autosomal Dominant Lewy Body 23Carcinoma, Transitional Cell 23Adenocarcinoma Of Esophagus 23Breast Neoplasms, Male 22Recurrence 21Unspecified Adult Solid Tumor, Protocol Specific 20Inflammatory Breast Neoplasms 20Fallopian Tube Neoplasms 20Melanoma 18

Interventions

Cisplatin 13Cetuximab 10Radiotherapy 7pembrolizumab 4Pemetrexed 4Fluorouracil 4Docetaxel 4Gemcitabine 3durvalumab 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Narrow Band Imaging 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gefitinib 2Drug Therapy 2Carboplatin 2tremelimumab 1niraparib 1monalizumab 1linrodostat 1dostarlimab 1capmatinib 1X-Rays 1Vitamin B 12 1Tirapazamine 1Tablets 1Surgical Flaps 1Sugars 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Laryngeal Diseases × Docetaxel × Clear all
NCT02128906 2026-04-16

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

University of Pittsburgh

Phase 2 Recruiting
120 enrolled
Head & Neck

Carcinoma, Squamous Cell, Laryngeal Diseases

NCT03340896 2025-09-02

SALTORL

Groupe Oncologie Radiotherapie Tete et Cou

Phase 3 Active not recruiting
256 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

NCT02126969 2023-03-13

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

University of Kentucky

Phase 2 Completed
45 enrolled 13 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

NCT01884259 2022-05-26

HNO-2

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 2 Completed
100 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡